Cargando…

Exploring the intersection of racism, antimicrobial resistance, and vaccine equity

Structural racism and systemic health inequities have an overwhelming and deadly impact on racially and ethnically minoritized groups. Antimicrobial resistance (AMR) is widely considered a global public health threat, and concerns that minoritized groups are disproportionately affected are increasin...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul-Mutakabbir, Jacinda C., Simiyu, Brenda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726476/
https://www.ncbi.nlm.nih.gov/pubmed/36483434
http://dx.doi.org/10.1017/ash.2022.283
_version_ 1784844794440187904
author Abdul-Mutakabbir, Jacinda C.
Simiyu, Brenda
author_facet Abdul-Mutakabbir, Jacinda C.
Simiyu, Brenda
author_sort Abdul-Mutakabbir, Jacinda C.
collection PubMed
description Structural racism and systemic health inequities have an overwhelming and deadly impact on racially and ethnically minoritized groups. Antimicrobial resistance (AMR) is widely considered a global public health threat, and concerns that minoritized groups are disproportionately affected are increasing. With the emergence and spread of AMR, novel therapies and prevention strategies are imperative. Coronavirus disease-19 (COVID-19) has highlighted stark imbalances in the hospitalization and death rates of minoritized individuals compared to their White counterparts, irrespective of the availability of targeted preventive therapies (ie, vaccinations). Thus, dialogue regarding the utility of vaccines used prophylactically to decrease the number of infectious diseases cases and the historical lack of vaccine equity and uptake across minoritized groups is needed. All of these factors work in concert to increase the burden of AMR and ultimately health disparities within minoritized communities. Herein, we provide historical context pertaining to the impact of structural racism on healthcare inequities in the United States, we explore racial and ethnic disparities in AMR, and we discuss the intersection of racism, AMR, and vaccine equity. Lastly, we offer recommendations to mitigate the described inequities.
format Online
Article
Text
id pubmed-9726476
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-97264762022-12-07 Exploring the intersection of racism, antimicrobial resistance, and vaccine equity Abdul-Mutakabbir, Jacinda C. Simiyu, Brenda Antimicrob Steward Healthc Epidemiol Commentary Structural racism and systemic health inequities have an overwhelming and deadly impact on racially and ethnically minoritized groups. Antimicrobial resistance (AMR) is widely considered a global public health threat, and concerns that minoritized groups are disproportionately affected are increasing. With the emergence and spread of AMR, novel therapies and prevention strategies are imperative. Coronavirus disease-19 (COVID-19) has highlighted stark imbalances in the hospitalization and death rates of minoritized individuals compared to their White counterparts, irrespective of the availability of targeted preventive therapies (ie, vaccinations). Thus, dialogue regarding the utility of vaccines used prophylactically to decrease the number of infectious diseases cases and the historical lack of vaccine equity and uptake across minoritized groups is needed. All of these factors work in concert to increase the burden of AMR and ultimately health disparities within minoritized communities. Herein, we provide historical context pertaining to the impact of structural racism on healthcare inequities in the United States, we explore racial and ethnic disparities in AMR, and we discuss the intersection of racism, AMR, and vaccine equity. Lastly, we offer recommendations to mitigate the described inequities. Cambridge University Press 2022-08-05 /pmc/articles/PMC9726476/ /pubmed/36483434 http://dx.doi.org/10.1017/ash.2022.283 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Commentary
Abdul-Mutakabbir, Jacinda C.
Simiyu, Brenda
Exploring the intersection of racism, antimicrobial resistance, and vaccine equity
title Exploring the intersection of racism, antimicrobial resistance, and vaccine equity
title_full Exploring the intersection of racism, antimicrobial resistance, and vaccine equity
title_fullStr Exploring the intersection of racism, antimicrobial resistance, and vaccine equity
title_full_unstemmed Exploring the intersection of racism, antimicrobial resistance, and vaccine equity
title_short Exploring the intersection of racism, antimicrobial resistance, and vaccine equity
title_sort exploring the intersection of racism, antimicrobial resistance, and vaccine equity
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726476/
https://www.ncbi.nlm.nih.gov/pubmed/36483434
http://dx.doi.org/10.1017/ash.2022.283
work_keys_str_mv AT abdulmutakabbirjacindac exploringtheintersectionofracismantimicrobialresistanceandvaccineequity
AT simiyubrenda exploringtheintersectionofracismantimicrobialresistanceandvaccineequity